Metastatic clear cell renal cell carcinoma demonstrating intense uptake on (68)Ga-DOTATATE positron emission tomography: Three case reports and a review of the literature

por Nadebaum, David P., Lee, Sze Ting, Nikfarjam, Mehrdad, Scott, Andrew M.
Publicado 2018

Radiolabeled Antibodies for Cancer Imaging and Therapy

por Parakh, Sagun, Lee, Sze Ting, Gan, Hui K., Scott, Andrew M.
Publicado 2022

Unusual location of recurrent mantle cell lymphoma on fluorodeoxyglucose-positron emission tomography despite complete metabolic resolution of previous sites of disease

por Froitzheim, Benjamin M. W., Boktor, Raef R., Lau, Eddie, Lee, Sze Ting
Publicado 2020

Impact of (18)F-FDG PET/CT on treatment of patients with differentiated thyroid carcinoma, negative (131)I whole body scan and elevated serum thyroglobulin

por Boktor, Raef R., Lee, Sze Ting, Berlangieri, Salvatore U., Scott, Andrew M.
Publicado 2022

The value of FDG PET/CT imaging in outcome prediction and response assessment of lymphoma patients treated with immunotherapy: a meta-analysis and systematic review

por Kiamanesh, Zahra, Ayati, Narjess, Sadeghi, Ramin, Hawkes, Eliza, Lee, Sze Ting, Scott, Andrew M.
Publicado 2022

Evaluation of (18)F-FMISO PET and (18)F-FDG PET Scans in Assessing the Therapeutic Response of Patients With Metastatic Colorectal Cancer Treated With Anti-Angiogenic Therapy

por Lee, Sze Ting, Tebbutt, Niall, Gan, Hui Kong, Liu, Zhanqi, Sachinidis, John, Pathmaraj, Kunthi, Scott, Andrew Mark
Publicado 2021

Molecular profiling of cetuximab and bevacizumab treatment of colorectal tumours reveals perturbations in metabolic and hypoxic response pathways

por Greening, David W., Lee, Sze Ting, Ji, Hong, Simpson, Richard J., Rigopoulos, Angela, Murone, Carmel, Fang, Catherine, Gong, Sylvia, O'Keefe, Graeme, Scott, Andrew M.
Publicado 2015

Correction: Molecular profiling of cetuximab and bevacizumab treatment of colorectal tumours reveals perturbations in metabolic and hypoxic response pathways

por Greening, David W., Lee, Sze Ting, Ji, Hong, Simpson, Richard J., Rigopoulos, Angela, Murone, Carmel, Fang, Catherine, Gong, Sylvia, O'Keefe, Graeme, Scott, Andrew M.
Publicado 2016

In vivo imaging of cellular proliferation in renal cell carcinoma using 18F-fluorothymidine PET

por Wong, Peter K., Lee, Sze Ting, Murone, Carmel, Eng, John, Lawrentschuk, Nathan, Berlangieri, Salvatore U., Pathmaraj, Kunthi, O’Keefe, Graeme J., Sachinidis, John, Byrne, Amanda J., Bolton, Damien M., Davis, Ian D., Scott, Andrew M.
Publicado 2014

Tumor volumes as a predictor of response to the anti-EGFR antibody drug conjugate depatuxizumab mafadotin

por Gan, Hui K, Parakh, Sagun, Lassman, Andrew B, Seow, Aidan, Lau, Eddie, Lee, Sze Ting, Ameratunga, Malaka, Perchyonok, Yuliya, Cao, Diana, Burvenich, Ingrid J G, O’Keefe, Graeme J, Rigopoulos, Angela, Gomez, Erica, Maag, David, Scott, Andrew M
Publicado 2021

First clinical study of a pegylated diabody (124)I-labeled PEG-AVP0458 in patients with tumor-associated glycoprotein 72 positive cancers

por Scott, Andrew M., Akhurst, Timothy, Lee, Fook-Thean, Ciprotti, Marika, Davis, Ian D., Weickhardt, Andrew J., Gan, Hui K., Hicks, Rodney J., Lee, Sze Ting, Kocovski, Pece, Guo, Nancy, Oh, Maggie, Mileshkin, Linda, Williams, Scott, Murphy, Declan, Pathmaraj, Kunthi, O'Keefe, Graeme J., Gong, Sylvia J., Pedersen, John S., Scott, Fiona E., Wheatcroft, Michael P., Hudson, Peter J.
Publicado 2020

[(18)F]-fluoroethyl-L-tyrosine (FET) in glioblastoma (FIG) TROG 18.06 study: protocol for a prospective, multicentre PET/CT trial

por Koh, Eng-Siew, Gan, Hui K, Senko, Clare, Francis, Roslyn J, Ebert, Martin, Lee, Sze Ting, Lau, Eddie, Khasraw, Mustafa, Nowak, Anna K, Bailey, Dale L, Moffat, Bradford A, Fitt, Greg, Hicks, Rodney J, Coffey, Robert, Verhaak, Roel, Walsh, Kyle M, Barnes, Elizabeth H, De Abreu Lourenco, Richard, Rosenthal, Mark, Adda, Lucas, Foroudi, Farshad, Lasocki, Arian, Moore, Alisha, Thomas, Paul A, Roach, Paul, Back, Michael, Leonard, Robyn, Scott, Andrew M
Publicado 2023

A clinical trial of non-invasive imaging with an anti-HIV antibody labelled with copper-64 in people living with HIV and uninfected controls

por McMahon, James H., Zerbato, Jennifer M., Lau, Jillian S.Y., Lange, Jaclyn L., Roche, Michael, Tumpach, Carolin, Dantanarayana, Ashanti, Rhodes, Ajantha, Chang, Judy, Rasmussen, Thomas A., Mackenzie, Charlene A., Alt, Karen, Hagenauer, Michelle, Roney, Janine, O‘Bryan, Jessica, Carey, Alexandra, McIntyre, Richard, Beech, Paul, O'Keefe, Graeme J., Wichmann, Christian W., Scott, Fiona E., Guo, Nancy, Lee, Sze-Ting, Liu, Zhanqi, Caskey, Marina, Nussenzweig, Michel C., Donnelly, Paul S., Egan, Gary, Hagemeyer, Christoph E., Scott, Andrew M., Lewin, Sharon R.
Publicado 2021